Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones

Gastroenterology

Volumn 127, Issue 3, 2004, Pages 792-801

  Dresner Pollak, Rivka ^a   Gelb, Nir ^b   Rachmilewitz, Daniel ^c   Karmeli, Fanny ^c   Weinreb, Miron ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; OSTEOCALCIN; PARATHYROID HORMONE; PYRIDONE DERIVATIVE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE FRAGILITY; BONE MARROW; BONE MASS; BONE METABOLISM; BONE STRENGTH; CANCELLOUS BONE; CELL CULTURE; COLITIS; CONTROLLED STUDY; CORTICAL BONE; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENTERITIS; EXPLANT; FEMUR; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; STROMA CELL; TIBIA; WILD TYPE;

EID: 4444366268     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.06.013     Document Type: Article

References (55)

1. J.E. Compston, D. Judd, E.O. Crawley, W.D. Evans, C. Evans, H.A. Church, E.M. Reid, J. Rhodes Osteoporosis in patients with inflammatory bowel disease Gut 28 1987 410 415
2. F. Pigot, C. Roux, S. Chaussade, D. Hardelin, O. Pelleter, T. Du Puy Montbrun, V. Listrat, M. Dougados, D. Couturier, B. Amor Low bone mineral density in patients with inflammatory bowel disease Dig Dis Sci 37 1992 1396 1403
3. D. Marshall, O. Johnell, H. Wedel Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures BMJ 312 1996 1254 1259
4. T.P. Van Staa, C. Cooper, L.S. Brusse, H. Leufkens, M.K. Javaid, N.K. Arden Inflammatory bowel disease and the risk of fracture Gastroenterology 125 2003 1591 1597
5. T. Card, J. West, R. Hubbard, R.F. Logan Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use a population based cohort study Gut 53 2004 251 255
6. C.N. Bernstein, J.F. Blanchard, W. Leslie, A. Wajda, B.N. Yu The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study Ann Intern Med 133 2000 795 799
7. R.H. Driscoll, S.C. Meredith, M. Sitrin, I.H. Rosenberg Vitamin D deficiency and bone disease in patients with Crohn's disease Gastroenterology 83 1982 1252 1258
8. V. Abitbol, C. Roux, S. Chaussade, S. Guillemant, S. Kolta, M. Dougados, D. Couturier, B. Amor Metabolic bone assessment in patients with inflammatory bowel disease Gastroenterology 108 1995 417 422
9. C.N. Bernstein, L.L. Seeger, J.W. Sayre, P.A. Anton, L. Artinian, F. Shanahan Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis J Bone Miner Res 10 1995 250 256
10. S. Ghosh, S. Cowen, W.J. Hannan, A. Ferguson Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis Gastroenterology 107 1994 1031 1039
11. I. Bjarnason, A. Macpherson, C. Mackintosh, M. Buxton-Thomas, I. Forgacs, C. Moniz Reduced bone density in patients with inflammatory bowel disease Gut 40 1997 228 233
12. S.W. Fox, T.J. Chambers Interferon-gamma directly inhibits TRANCE-induced osteoclastogenesis Biochem Biophys Res Commun 276 2000 868 872
13. M.S. Nanes, W.M. McKoy, S.J. Marx Inhibitory effects of TNFα and interferon-gamma on DNA and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8) Endocrinology 124 1989 339 345
14. D.D. Smith, M. Gowen, G.R. Mundy Effects of interferon-gamma and other cytokines on collagen synthesis in fetal rat bone cultures Endocrinology 120 1987 2494 2499
15. R. Yoshihara, S. Shiozawa, Y. Imai, T. Fujita Tumor necrosis factor α and interferon-gamma inhibit proliferation and alkaline phosphatase activity of human osteoblastic SaOS-2 cell line Lymphokine Res 9 1990 59 66
16. L. Gilbert, X. He, P. Farmer, S. Boden, M. Kozlowski, J. Rubin, M.S. Nanes Inhibition of osteoblast differentiation by tumor necrosis factor-α Endocrinology 141 2000 3956 3964
17. L. Gilbert, X. He, P. Farmer, J. Rubin, H. Drissi, A.J. van Wijnen, J.B. Lian, G.S. Stein, M.S. Nanes Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2αA) is inhibited by tumor necrosis-α J Biol Chem 277 2002 2695 2701
18. K.J. Armour, K.E. Armour, R.J. Van't Hof, D.M. Reid, X.Q. Wei, F.Y. Liew, S.H. Ralston Activation of the iNOS pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis Arthritis Rheum 44 2001 2790 2796
19. M. Hukkanen, F.J. Hughes, L.D. Buttery, S.S. Gross, T.J. Evans, S. Seddon, V. Riveros-Moreno, I. Mcintyre, J.M. Polak Cytokine-stimulated expression of iNOS by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity Endocrinology 136 1995 5445 5453
20. P.D. Damoulis, P.V. Hauschka Nitric oxide acts in conjunction with pro-inflammatory cytokines to promote cell death in osteoblasts J Bone Miner Res 3 1997 412 422
21. G. Roodman Interleukin-6 an osteoporotic factor? J Bone Miner Res 7 1992 475 478
22. H. Kitaura, N. Nagata, Y. Fujimura, H. Hotokezaka, N. Yoshida, K. Nakayama Effect of IL-12 on TNF-alpha-mediated osteoclast formation in bone marrow cells apoptosis mediated by Fas/Fas ligand interaction J Immunol 169 2002 4732 4738
23. C.L. Lin, C. Moniz, T.J. Chambers, J.M. Chow Colitis causes bone loss in rats through suppression of bone formation Gastroenterology 111 1996 1263 1271
24. W. Fries, D. Giacomin, M. Plebani, A. Martin Effect of experimental colitis on bone metabolism in the rat Digestion 55 1994 229 233
25. R. Kuhn, J. Lohler, D. Rennick, K. Rajewsky, W. Muller Interleukin-10-deficient mice develop chronic enterocolitis Cell 75 1993 263 274
26. D.J. Berg, N. Davidson, R. Kuhn, W. Muller, S. Menon, G. Holland, L. Thompson-Snipes, M.W. Leach, D. Rennick Enterocolitis and colon cancer in IL-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses J Clin Invest 98 1996 1010 1020
27. M.W. Leach, N.J. Davidson, M.M. Fort, F. Powrie, D.M. Rennick The role of IL-10 in inflammatory bowel disease "of mice and men." Toxicol Pathol 27 1999 123 133
28. S. Schreiber, R.N. Fedorak, O.H. Nielsen, G. Wild, C.N. Williams, S. Nikolaus, M. Jacyna, B.A. Lashner, A. Gangl, P. Rutgeerts, K. Isaacs, S.J. Van Deventer, J.C. Koningsberger, M. Cohard, A. LeBeaut, S.B. Hanauer Safety and efficacy of recombinant human IL-10 in chronic active Crohn's disease Crohn's disease IL-10 Cooperative Study Group Gastroenterology 119 2000 1461 1472
29. R.N. Fedorak, A. Gangl, C.O. Elson, P. Rutgeerts, S. Schrieber, G. Wild, S.B. Hanauer, A. Kilian, M. Cohard, A. LeBeaut, B. Feagan Recombinant human IL-10 in the treatment of patients with mild to moderately active Crohn's disease The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Gastroenterology 119 2000 1473 1482
30. P. Sharon, M. Ligumsky, D. Rachmilewitz, U. Zor Role of prostaglandins in ulcerative colitis Enhanced production during active disease and inhibition by sulfasalazine Gastroenterology 75 1978 638 640
31. M. Weinreb, G.A. Rodan, D.D. Thompson Depression of osteoblastic activity in immobilized limbs of suckling rats J Bone Miner Res 1991 725 731
32. 2 on production of new cancellous bone in the axial skeleton of ovariectomized rats Bone 11 1990 103 113
33. A.M. Parfitt, M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, P.J. Meunier, S.M. Ott, R.R. Recker Bone histomorphometry standardization of nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee J Bone Miner Res 2 1987 595 610
34. D. Rachmilewitz, F. Karmeli, K. Takabayashi, T. Hayashi, L. Leider-Trejo, J. Lee, L.M. Leoni, E. Raz Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis Gastroenterology 122 2002 1428 1441
35. 2 in long bones and calvariae of young rats J Endocrinol 156 1998 51 57
36. C. Maniatopoulos, J. Sodek, A.H. Melcher Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats Cell Tissue Res 254 1988 317 330
37. 2 in young rats increases the osteogenic capacity of bone marrow Bone 20 1997 521 526
38. M.M. Bradford A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Ann Biochem 72 1976 248 254
39. J.M. Owens, A.C. Gallagher, T.J. Chambers IL-10 modulates formation of osteoclasts in mureine hemopoetic cultures J Immunol 157 1996 936 940
40. L.X. Xu, T. Kukita, A. Kukita, T. Otsuka, Y. Niho, T. Iijima Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system J Cell Physiol 165 1995 624 629
41. M.H. Hong, H. Williams, C.H. Jin, J.W. Pike The inhibitory effect of interleukin-10 on mouse osteoclast formation involves novel tyrosine- phosphorylated proteins J Bone Miner Res 15 2000 911 918
42. H. Sasaki, L. Hou, A. Belani, C.Y. Wang, T. Uchiyama, R. Muller, P. Stashenko IL-10 but not IL-4 suppresses infection-stimulated bone resorption in vivo J Immunol 165 2000 3626 3630
43. P. Van Vlasselaer, R. Van Den Heuvel, U. Van Gorp, R. de Waal Malefyt Interleukin 10 inhibits the osteogenic activity of mouse bone marrow Blood 82 1993 2361 2370
44. P. Van Vlasselaer, B. Borremans, U. van Gorp, J.R. Dasch, R. De Waal-Malefyt Interleukin 10 inhibits transforming growth factor-β (TGF-β) synthesis required for osteogenic commitment of mouse bone marrow cells J Cell Biol 124 1994 569 577
45. A. Al-Rasheed, H. Scheerens, A.K. Srivastava, D.M. Rennick, D.N. Tatakis Accelerated alveolar bone loss in mice lacking interleukin-10 late onset J Periodontal Res 39 2004 194 198
46. A. Al-Rasheed, H. Scheerens, D.M. Rennick, H.M. Fletcher, D.N. Tatakis Accelerated alveolar bone loss in mice lacking interleukin-10 J Dent Res 82 2003 632 635
47. F.A. Sylvester, N. Wyzga, J.S. Hymans, G.A. Gronowicz Effect of Crohn's disease on bone metabolism in vitro a role for interleukin-6 J Bone Miner Res 17 2002 695 702
48. S. Varghese, N. Wyzga, A.M. Griffiths, F.A. Sylvester Effects of serum from children with newly diagnosed Crohn's disease on primary cultures of rat osteoblasts J Pediatr Gastroeneterol Nutr 35 2002 641 648
49. P.I. Croucher, S. Vedi, R.J. Motley, N.J. Garrahan, M.R. Stanson, J.E. Compston Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease Osteoporosis Int 3 1993 236 241
50. D.M. McCafferty, E. Sihota, M. Muscara, J.L. Wallace, K.A. Sharkey, P. Kubes Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice Am J Physiol Gastrointest Liver 279 2000 G90 G99
51. S.W. Fox, J.M. Chow Nitric oxide synthase expression in bone cells Bone 23 1998 1 6
52. S. Yakar, C.J. Rosen, W.G. Beamer, C.L. Ackert-Bicknell, Y. Wu, J.L. Liu, G.T. Ooi, J. Setser, J. Frystyk, Y.R. Boisclair, D. LeRoith Circulating levels of IGF-1 directly regulate bone growth and density J Clin Invest 110 2002 771 781
53. T. El-Haj, S. Poole, M.J. Farthing Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis Gut 46 2000 694 700
54. K.H. Katsarakia, A. Tsatsoulis, D. Christodoulou, A. Challa, E.V. Katsar Tsianos Reduced serum insulin-like growth factor-1 (IGF-1) and binding protein-3 levels in adults with inflammatory bowel disease Growth Horm IGF Res 11 2001 364 367
55. S. Bourrin, A. Toromanoff, P. Ammann, J.P. Bonjour, R. Rizzoli Dietary protein deficiency induces osteoporosis in aged male rats J Bone Miner Res 15 2000 1555 1563